| | |
| | |
| Clinical data | |
|---|---|
| Trade names | Epigen, Glycyron |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral, intravenous |
| ATC code | |
| Pharmacokinetic data | |
| Metabolism | Hepatic and by intestinal bacteria |
| Elimination half-life | 6.2–10.2 hours [1] |
| Excretion | Faeces, urine (0.31–0.67%) [2] |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| E number | E958 (glazing agents, ...) |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.014.350 |
| Chemical and physical data | |
| Formula | C42H62O16 |
| Molar mass | 822.942 g·mol−1 |
| 3D model (JSmol) | |
| Solubility in water | 1–10 mg/mL (20 °C) |
| |
| |
Glycyrrhizin (glycyrrhizic acid or glycyrrhizinic acid) is the chief sweet-tasting constituent of Glycyrrhiza glabra (liquorice) root. Structurally, it is a saponin used as an emulsifier and gel-forming agent in foodstuffs and cosmetics. Its aglycone is enoxolone.
After oral ingestion, glycyrrhizin is hydrolysed to 18β-glycyrrhetinic acid (enoxolone) by intestinal bacteria. After absorption from the gut, 18β-glycyrrhetinic acid is metabolised to 3β-monoglucuronyl-18β-glycyrrhetinic acid in the liver. This metabolite circulates in the bloodstream. Consequently, its oral bioavailability is poor.[ quantify ] Most of it is eliminated by bile and only a minor part (0.31–0.67%) by urine. [3] After oral ingestion of 600 mg of glycyrrhizin the metabolite appeared in urine after 1.5 to 14 hours. Maximal concentrations (0.49 to 2.69 mg/L) were achieved after 1.5 to 39 hours and metabolite can be detected in the urine after 2 to 4 days. [3]
The polypharmacological effect of glycyrrhizinic acid, which has at least 12 types of activity [4] (antitumor [5] , hepatoprotective [6] , immunomodulatory, antidiabetic, nephroprotective, cardioprotective, neuroprotective, atheroprotective, anti-inflammatory, antithrombotic, etc.), is closely related to its interaction with various cellular targets. Approximately 88 cellular proteins [4] have been experimentally identified as potential targets of glycyrrhizic acid, including cytochromes P450, UDP-glucouronosyltransferases, oxidoreductases, and proteins involved in amino acid metabolism and steroid hormone biosynthesis.
Glycyrrhizin is obtained as an extract from licorice root after maceration and boiling in water. [7] Licorice extract (glycyrrhizin) is sold in the United States as a liquid, paste, or spray-dried powder. [7] When in specified amounts, it is approved for use as a flavor and aroma in manufactured foods, beverages, candies, dietary supplements, and seasonings. [7] It is 30 to 50 times as sweet as sucrose (table sugar). [8]
The most widely reported side effect of glycyrrhizin use via consumption of black liquorice is reduction of blood potassium levels, which can affect body fluid balance and function of nerves. [9] [10] Chronic consumption of black licorice, even in moderate amounts, is associated with an increase in blood pressure, [10] may cause irregular heart rhythm, and may have adverse interactions with prescription drugs. [9] In extreme cases, death can occur as a result of excess consumption. [11] [12]
Media related to Glycyrrhizin at Wikimedia Commons